Search

Search results

116 results found

High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia

Publication: Bill

Zhang, H., D. M. Frendl, Z. Wang, and A. F. Olumi. 2020. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.

Radical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trial

Publication: Bill

Reitblat, C., A. Fleishman, I. A. Kaplan, K. D. Stensland, A. V. D’Amico, A. F. Olumi, A. A. Wagner, et al. 2021. Radical Prostatectomy versus External Beam Radiation Therapy for High-Grade, Clinically Localized Prostate Cancer: Emulation of a Target Clinical Trial.

Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder

Publication: Bill

Softness, K., S. Kaul, A. Fleishman, J. Efstathiou, J. Bellmunt, S. P. Kim, R. Korets, et al. 2022. Radical Cystectomy versus Trimodality Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder.

5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care

Publication: Bill

Vaselkiv, J. B., C. Ceraolo, K. M. Wilson, C. H. Pernar, E. M. Rencsok, K. H. Stopsack, S. T. Grob, et al. 2022. 5-Alpha Reductase Inhibitors and Prostate Cancer Mortality Among Men With Regular Access to Screening and Health Care.

Dr. Zongwei Wang

he/him

Person: Principle Investigator, Assistant Professor

Dr. Wang is the Assistant Professor in the Department of Urological Surgery at Beth Israel Deaconess Medical Center and leads a joint laboratory with department chair Dr. Aria F. Olumi. The Olumi/Wang laboratory investigates SRD5A2-related non-androgenic pathways that contribute to the maintenance...

Ectonucleotidases and purinergic receptors in mouse prostate gland

Publication: Bill

Yu, J., C. Sharkey, A. F. Olumi, and Z. Wang. 2025. Ectonucleotidases and Purinergic Receptors in Mouse Prostate Gland.

Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland

Publication: Bill

Al-Faouri, R., C. Sharkey, B. Gershman, L. L. Tsai, Z. Wang, and A. F. Olumi. 2024. Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland.

Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder

Publication: Bill

Mao, W., T. Zhang, H. Chen, S. Barge, Z. Wang, A. Olumi, S. Alper, and W. Yu. 2025. Expression and Distribution of Activin-Follistatin-Inhibin Axis in the Urinary Bladder.

Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy

Publication: Bill

Schaufler, C., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2024. Immediate Radiotherapy versus Observation in Patients With Node-Positive Prostate Cancer After Radical Prostatectomy.

Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts

Publication: Bill

San Francisco, I. F., W. C. DeWolf, D. M. Peehl, and A. F. Olumi. 2004. Expression of Transforming Growth Factor-Beta 1 and Growth in Soft Agar Differentiate Prostate Carcinoma-Associated Fibroblasts from Normal Prostate Fibroblasts.